PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26221F0240Chemistry reagents — Ortho-Clinical Diagnostics, Inc

Ortho-Clinical Diagnostics, Inc holds $57.6M across 1,615 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent V797D60637. Competition previously drew 4 offers. PoP ended Feb 28, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

262-Network Contract Office 22 (36C262)
Awarding office
Ortho-Clinical Diagnostics, Inc
Recipient
Feb 28, 2023
PoP end
$1M
Obligated
$2.8M
Potential
334516
NAICS
6640
PSC
4 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ortho-Clinical Diagnostics, Inc — $90

Contract facts

Federal
Contract number36C26221F0240
Also listed as36C262-21-F-0240
Also listed asV797D60637-36C26221F0240
Agency262-Network Contract Office 22 (36C262)
Awarding office262-Network Contract Office 22 (36C262)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentOrtho-Clinical Diagnostics, Inc
CAGE1C0L5
UEIJG5JF2JQJ121
NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6640
Parent IDIQ / IDVV797D60637
Place of performanceLONG BEACH CA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startApr 1, 2021
PoP end (current)Feb 28, 2023
Obligated$1M
Current value$2.8M
Potential value$2.8M

CHEMISTRY REAGENTS is a federal award for 262-Network Contract Office 22 (36C262) held by Ortho-Clinical Diagnostics, Inc. Estimated value $2.8M ($1M obligated). Current period of performance ends Feb 28, 2023. Last award drew 4 bidders. Place of performance: LONG BEACH CA.

Recompete timing

Public
Past PoP end (1270 days ago)

Current PoP ended Feb 28, 2023 (1270 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Ortho-Clinical Diagnostics, Inc$57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($57.6M) · all agencies
Department of Veterans Affairs (VA)$26.2M · 45%Department of Defense (DOD)$22.1M · 38%Department of Health and Human Services (HHS)$8.6M · 15%General Services Administration (GSA)$297K · 1%
Open full company profile

Related awards

Same parent · incumbent
75H71024F80169
FY2024 LAB VITROS7600 REAGENTS/SUPPLIES TO BE ORDERED ON AN "AS NEEDED" BASIS, PART OF CPT…
$2.1M
Aug 31, 2026
FA466121F0075
VITROS CHEMICAL ANALYZER MAINTENANCE AND CALIBRATION
$336K
Aug 31, 2026
36C25925N0518
BLOOD BANK GEL ANALYZER COST PER TEST - SLC
$114K
Sep 6, 2026
36C25025N0968
BLOOD BANK ANALYZER, REAGENTS AND CONSUMABLES
$239K
Sep 14, 2026
FA489721F0042
CHEM ANALYZER SERVICES - EXERCISE OPTION YEAR 1
$717K
Sep 29, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C26221F0240?

36C26221F0240 (Chemistry reagents) is a 262-Network Contract Office 22 (36C262) award with a potential value of $2.8M, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C262-21-F-0240?

36C262-21-F-0240 is the dashed form of PIID 36C26221F0240 (Chemistry reagents), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26221F0240?

262-Network Contract Office 22 (36C262) awarded 36C26221F0240 to Ortho-Clinical Diagnostics, Inc (potential $2.8M).

Who is the incumbent on 36C26221F0240?

Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Feb 28, 2023.

When does Ortho-Clinical Diagnostics, Inc’s 36C26221F0240 come up for recompete?

SCOUT tracks a period-of-performance end of Feb 28, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26221F0240